Skip to main content
Premium Trial:

Request an Annual Quote

Amid Organizational Change, Predicant to Auction $6M Worth of Equipment

NEW YORK, Jan. 3 (GenomeWeb News) - Predicant Biosciences will auction $6 million worth of "bioscience" and information technology equipment, said the firm arranging the sale.


The auction, to be held Jan. 10, is being managed by Cowan Alexander and Asset Reliance International.


According to Don Cowan, president of the auction firm, "general lab and analytical instruments" such as spectrometers, detectors, coolers, microscope cameras, storage systems, machining centers, and vacuum pumps will be sold.


As reported by GenomeWeb News in October, Predicant took on $7.5 million in debt to develop and market protein biomarker technology for diagnostic tests.


Buyers can inspect items and place bids at the auction house or over the Internet during the webcast. The auction will begin 11 a.m. PST.


Predicant did not respond to calls seeking comment, but a recorded message indicated an "organizational change" was underway.

The Scan

Review of Approval Process

Stat News reports the Department for Health and Human Services' Office of the Inspector General is to investigate FDA's approval of Biogen's Alzheimer's disease drug.

Not Quite Right

A new analysis has found hundreds of studies with incorrect nucleotide sequences reported in their methods, according to Nature News.

CRISPR and mRNA Together

Time magazine reports on the use of mRNA to deliver CRISPR machinery.

Nature Papers Present Smartphone Platform for DNA Diagnosis of Malaria, Mouse Lines for Epigenomic Editing

In Nature this week: a low-cost tool to detect infectious diseases like malaria, and more.